A Trial Of CVX-060, An Anti-Angiogenic COVX-Body, In Combination With Sunitinib In Patients With Advanced Renal Cell Carcinoma

Clinical trial NCT00982657 · TERMINATED

Trial details

NCT number

NCT00982657

Sponsor

Pfizer

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2009-09-01

Primary completion

2014-03-01

Enrollment

34

View on ClinicalTrials.gov